Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow Reinvestment Rate
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Reinvestment Rate of 1.76x as of March 2025, reinvesting Rs8.20 Billion (capex Rs2.72 Billion plus investments Rs-5.48 Billion) from operating cash flow of Rs4.65 Billion. Check Akums Drugs and Pharmaceutical (AKUMS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Akums Drugs and Pharmaceutical across 4 annual periods. Explore Akums Drugs and Pharmaceutical (AKUMS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year capital reinvestment analysis for Akums Drugs and Pharmaceutical. For live market cap and broader valuation context, see Akums Drugs and Pharmaceutical market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.76x | Rs8.20 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +36.9% |
| 2024 | 1.29x | Rs6.42 Billion | Rs4.98 Billion | Rs3.11 Billion | ▼ -64.1% |
| 2023 | 3.59x | Rs6.33 Billion | Rs1.77 Billion | Rs3.29 Billion | ▼ -76.8% |
| 2022 | 15.46x | Rs4.92 Billion | Rs318.54 Million | Rs2.58 Billion | — |